T1	Intervention 583 728	receive anti-Helicobacter pylori triple therapy and/or dietary supplementation with ascorbic acid, beta-carotene, or their corresponding placebos
T2	Intervention 730 816	Gastric biopsy specimens taken at baseline were compared with those taken at 72 months
T3	Intervention 818 1077	Relative risks of progression, no change, and regression from multifocal nonmetaplastic atrophy and intestinal metaplasia were analyzed with multivariate polytomous logistic regression models to estimate treatment effects. All statistical tests were two-sided
